Meeting
2018 ASCO Annual Meeting
Low-toxic myeloablative conditioning regimen in haploidentical hematopietic stem cell transplantation for elderly patients with acute myeloid leukemia.
Authors
Cynthia Aristei
Radiation Oncology Section, Department of Surgery and Biomedical Sciences, University of Perugia and Perugia General Hospital, Perugia, Italy
Cynthia Aristei , Valentina Lancellotta , Claudio Zucchetti , Simonetta Saldi , Lucia Amico , Martina Iacco , Andrea Velardi , Massimo Fabrizio Martelli
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Hematologic Malignancies—Leukemia, Myelodysplastic Syndromes, and Allotransplant
Track
Hematologic Malignancies—Leukemia, Myelodysplastic Syndromes, and Allotransplant
Sub Track
Acute Leukemia
Citation
J Clin Oncol 36, 2018 (suppl; abstr 7038)
DOI
10.1200/JCO.2018.36.15_suppl.7038
Abstract #
7038
Poster Bd #
98
Abstract Disclosures
Similar Posters
Poster
2019 ASCO Annual Meeting
A phase II study of myeloablative allogeneic hematopoietic stem cell transplantation (aHSCT) for acute lymphoblastic leukemia (ALL) in older patients using fludarabine and total body irradiation (Flu/TBI).
First Author: Omer Hassan JAMY
Poster
2023 ASCO Annual Meeting
Myeloablative fractionated busulfan-based conditioning regimen in patients with AML and MDS: Results of a randomized clinical trial comparing 2 fractionation schedules.
First Author: Uday R. Popat
Poster
2022 ASCO Annual Meeting
Treatment patterns and real-world effectiveness of rituximab maintenance in older patients with mantle cell lymphoma: A population-based analyses.
First Author: Mengyang Di
Poster
2014 ASCO Annual Meeting
Treatment patterns, mortality, and costs of care in unfit patients (pts) with relapsed chronic lymphocytic leukemia (CLL).
First Author: Helen Varker